<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35935957</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Advances in understanding interferon-mediated immune responses to enteric viruses in intestinal organoids.</ArticleTitle><Pagination><StartPage>943334</StartPage><MedlinePgn>943334</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">943334</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2022.943334</ELocationID><Abstract><AbstractText>Interferons (IFN) are antiviral cytokines with critical roles in regulating pathogens at epithelial barriers, but their capacity to restrict human enteric viruses has been incompletely characterized in part due to challenges in cultivating some viruses <i>in vitro</i>, particularly human norovirus. Accordingly, advancements in the development of antiviral therapies and vaccine strategies for enteric viral infections have been similarly constrained. Currently emerging is the use of human intestinal enteroids (HIEs) to investigate mechanisms of human enteric viral pathogenesis. HIEs provide a unique opportunity to investigate host-virus interactions using an <i>in vitro</i> system that recapitulates the cellular complexity of the <i>in vivo</i> gastrointestinal epithelium. This approach permits the exploration of intestinal epithelial cell interactions with enteric viruses as well as the innate immune responses mediated by IFNs and IFN-stimulated genes. Here, we describe recent findings related to the production, signaling, and function of IFNs in the response to enteric viral infections, which will ultimately help to reveal important aspects of pathogenesis and facilitate the future development of therapeutics and vaccines.</AbstractText><CopyrightInformation>Copyright © 2022 Nolan and Baldridge.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nolan</LastName><ForeName>Lila S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Newborn Medicine, Washington University School of Medicine, St. Louis Children's Hospital, St. Louis, MO, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baldridge</LastName><ForeName>Megan T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F32 DK130248</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI127552</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI139314</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI141478</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>9008-11-1</RegistryNumber><NameOfSubstance UI="D007372">Interferons</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007372" MajorTopicYN="N">Interferons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009940" MajorTopicYN="N">Organoids</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">astrovirus</Keyword><Keyword MajorTopicYN="N">enteric virus</Keyword><Keyword MajorTopicYN="N">enteroid</Keyword><Keyword MajorTopicYN="N">interferon</Keyword><Keyword MajorTopicYN="N">interferon-stimulated genes</Keyword><Keyword MajorTopicYN="N">norovirus</Keyword><Keyword MajorTopicYN="N">organoid</Keyword><Keyword MajorTopicYN="N">rotavirus</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor CW declared a past co-authorship with the author MB.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>8</Day><Hour>3</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35935957</ArticleId><ArticleId IdType="pmc">PMC9354881</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.943334</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Troeger C, Blacker BF, Khalil IA, Rao PC, Cao S, Zimsen SR, et al. . Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the global burden of disease study 2016. Lancet Infect Dis (2018) 18:1211–28. doi: 10.1016/S1473-3099(18)30362-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(18)30362-1</ArticleId><ArticleId IdType="pmc">PMC6202444</ArticleId><ArticleId IdType="pubmed">30243583</ArticleId></ArticleIdList></Reference><Reference><Citation>Bányai K, Estes MK, Martella V, Parashar UD. Viral gastroenteritis. Lancet (London England) (2018) 392:175–86. doi: 10.1016/S0140-6736(18)31128-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)31128-0</ArticleId><ArticleId IdType="pmc">PMC8883799</ArticleId><ArticleId IdType="pubmed">30025810</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal S, Hassan E, Baldridge MT. Experimental methods to study the pathogenesis of human enteric rna viruses. Viruses (2021) 13:1–21. doi: 10.3390/v13060975</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13060975</ArticleId><ArticleId IdType="pmc">PMC8225081</ArticleId><ArticleId IdType="pubmed">34070283</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta D, Clevers H. Organoid culture systems to study host-pathogen interactions. Curr Opin Immunol (2017) 48:15–22. doi: 10.1016/j.coi.2017.07.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2017.07.012</ArticleId><ArticleId IdType="pmc">PMC7126332</ArticleId><ArticleId IdType="pubmed">28756233</ArticleId></ArticleIdList></Reference><Reference><Citation>Zachos NC, Kovbasnjuk O, Foulke-Abel J, In J, Blutt SE, De Jonge HR, et al. . Human enteroids/colonoids and intestinal organoids functionally recapitulate normal intestinal physiology and pathophysiology. J Biol Chem (2016) 291:3759–66. doi: 10.1074/jbc.R114.635995</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R114.635995</ArticleId><ArticleId IdType="pmc">PMC4759158</ArticleId><ArticleId IdType="pubmed">26677228</ArticleId></ArticleIdList></Reference><Reference><Citation>Boonekamp KE, Dayton TL, Clevers H. Intestinal organoids as tools for enriching and studying specific and rare cell types: advances and future directions. J Mol Cell Biol (2020) 12:562–8. doi: 10.1093/jmcb/mjaa034</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mjaa034</ArticleId><ArticleId IdType="pmc">PMC7683021</ArticleId><ArticleId IdType="pubmed">32667995</ArticleId></ArticleIdList></Reference><Reference><Citation>Co JY, Margalef-Català M, Li X, Mah AT, Kuo CJ, Monack DM, et al. . Controlling epithelial polarity: A human enteroid model for host-pathogen interactions. Cell Rep (2019) 26:2509–20.e4. doi: 10.1016/j.celrep.2019.01.108</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.01.108</ArticleId><ArticleId IdType="pmc">PMC6391775</ArticleId><ArticleId IdType="pubmed">30811997</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill DR, Spence JR. Gastrointestinal organoids: Understanding the molecular basis of the host–microbe interface. Cell Mol Gastroenterol Hepatol (2017) 3:138–49. doi: 10.1016/j.jcmgh.2016.11.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmgh.2016.11.007</ArticleId><ArticleId IdType="pmc">PMC5331777</ArticleId><ArticleId IdType="pubmed">28275681</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrò C, Novellasdemunt L, Li VSW. A brief history of organoids. Am J Physiol - Cell Physiol (2020) 319:C151–65. doi: 10.1152/ajpcell.00120.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00120.2020</ArticleId><ArticleId IdType="pmc">PMC7468890</ArticleId><ArticleId IdType="pubmed">32459504</ArticleId></ArticleIdList></Reference><Reference><Citation>Ettayebi K, Tenge VR, Cortes-Penfield NW, Crawford SE, Neill FH, Zeng X-L, et al. . New insights and enhanced human norovirus cultivation in human intestinal enteroids. mSphere (2021) 6:e01136–20. doi: 10.1128/mSphere.01136-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mSphere.01136-20</ArticleId><ArticleId IdType="pmc">PMC7885322</ArticleId><ArticleId IdType="pubmed">33504663</ArticleId></ArticleIdList></Reference><Reference><Citation>Triana S, Stanifer ML, Metz-Zumaran C, Shahraz M, Mukenhirn M, Kee C, et al. . Single-cell transcriptomics reveals immune response of intestinal cell types to viral infection. Mol Syst Biol (2021) 17:e9833. doi: 10.15252/msb.20209833</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.20209833</ArticleId><ArticleId IdType="pmc">PMC8311733</ArticleId><ArticleId IdType="pubmed">34309190</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartfeld S, Clevers H. Organoids as model for infectious diseases: Culture of human and murine stomach organoids and microinjection of helicobacter pylori. J Vis Exp (2015) 2015:1–9. doi: 10.3791/53359</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/53359</ArticleId><ArticleId IdType="pmc">PMC4692704</ArticleId><ArticleId IdType="pubmed">26650279</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartfeld S, Bayram T, van de Wetering M, Huch M, Begthel H, Kujala P, et al. . In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection. Gastroenterology (2015) 148:126–36.e6. doi: 10.1053/j.gastro.2014.09.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2014.09.042</ArticleId><ArticleId IdType="pmc">PMC4274199</ArticleId><ArticleId IdType="pubmed">25307862</ArticleId></ArticleIdList></Reference><Reference><Citation>Co JY, Margalef-Català M, Monack DM, Amieva MR. Controlling the polarity of human gastrointestinal organoids to investigate epithelial biology and infectious diseases. Nat Protoc (2021) 16:5171–92. doi: 10.1038/s41596-021-00607-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41596-021-00607-0</ArticleId><ArticleId IdType="pmc">PMC8841224</ArticleId><ArticleId IdType="pubmed">34663962</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingle H, Peterson S, Baldridge M. Distinct effects of type I and III interferons on enteric viruses. Viruses (2018) 10:46. doi: 10.3390/v10010046</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10010046</ArticleId><ArticleId IdType="pmc">PMC5795459</ArticleId><ArticleId IdType="pubmed">29361691</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoenborn JR, Wilson CB. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol (2007) 96:41–101. doi: 10.1016/S0065-2776(07)96002-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0065-2776(07)96002-2</ArticleId><ArticleId IdType="pubmed">17981204</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemann EA, Gale M, Savan R. Interferon lambda genetics and biology in regulation of viral control. Front Immunol (2017) 8:1707. doi: 10.3389/fimmu.2017.01707</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01707</ArticleId><ArticleId IdType="pmc">PMC5723907</ArticleId><ArticleId IdType="pubmed">29270173</ArticleId></ArticleIdList></Reference><Reference><Citation>Richmond CA, Rickner H, Shah MS, Ediger T, Deary L, Zhou F, et al. . JAK/STAT-1 signaling is required for reserve intestinal stem cell activation during intestinal regeneration following acute inflammation. Stem Cell Rep (2018) 10:17–26. doi: 10.1016/j.stemcr.2017.11.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.11.015</ArticleId><ArticleId IdType="pmc">PMC5768934</ArticleId><ArticleId IdType="pubmed">29276155</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena K, Simon LM, Zeng X-L, Blutt SE, Crawford SE, Sastri NP, et al. . A paradox of transcriptional and functional innate interferon responses of human intestinal enteroids to enteric virus infection. Proc Natl Acad Sci U.S.A. (2017) 114:E570–9. doi: 10.1073/pnas.1615422114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1615422114</ArticleId><ArticleId IdType="pmc">PMC5278484</ArticleId><ArticleId IdType="pubmed">28069942</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker FC, Sridhar PR, Baldridge MT. Differential roles of interferons in innate responses to mucosal viral infections. Trends Immunol (2021) 42:1009–23. doi: 10.1016/j.it.2021.09.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2021.09.003</ArticleId><ArticleId IdType="pmc">PMC8496891</ArticleId><ArticleId IdType="pubmed">34629295</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingle H, Hassan E, Gawron J, Mihi B, Li Y, Kennedy EA, et al. . Murine astrovirus tropism for goblet cells and enterocytes facilitates an IFN-λ response in vivo and in enteroid cultures. Mucosal Immunol (2021) 14:751–61. doi: 10.1038/s41385-021-00387-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-021-00387-6</ArticleId><ArticleId IdType="pmc">PMC8085034</ArticleId><ArticleId IdType="pubmed">33674763</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingle H, Lee S, Ai T, Orvedahl A, Rodgers R, Zhao G, et al. . Viral complementation of immunodeficiency confers protection against enteric pathogens via interferon-λ. Nat Microbiol (2019) 4:1120–8. doi: 10.1038/s41564-019-0416-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-019-0416-7</ArticleId><ArticleId IdType="pmc">PMC6588490</ArticleId><ArticleId IdType="pubmed">30936486</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldridge MT, Lee S, Brown JJ, McAllister N, Urbanek K, Dermody TS, et al. . Expression of Ifnlr1 on intestinal epithelial cells is critical to the antiviral effects of interferon lambda against norovirus and reovirus. J Virol (2017) 91:e02079–16. doi: 10.1128/jvi.02079-16</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02079-16</ArticleId><ArticleId IdType="pmc">PMC5355594</ArticleId><ArticleId IdType="pubmed">28077655</ArticleId></ArticleIdList></Reference><Reference><Citation>Nice TJ, Baldridge MT, McCune BT, Norman JM, Lazear HM, Artyomov M, et al. . Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity. Science (2015) 347:269–73. doi: 10.1126/science.1258100</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1258100</ArticleId><ArticleId IdType="pmc">PMC4398891</ArticleId><ArticleId IdType="pubmed">25431489</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman MC, Wells AI, Ciomperlik-Patton J, Myerburg MM, Yang L, Konopka-Anstadt J, et al. . Respiratory and intestinal epithelial cells exhibit differential susceptibility and innate immune responses to contemporary EV-D68 isolates. Elife (2021) 10:1–21. doi: 10.7554/eLife.66687</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.66687</ArticleId><ArticleId IdType="pmc">PMC8285104</ArticleId><ArticleId IdType="pubmed">34196272</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernández PP, Mahlakoiv T, Yang I, Schwierzeck V, Nguyen N, Guendel F, et al. . Interferon-λ and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection. Nat Immunol (2015) 16:698–707. doi: 10.1038/ni.3180</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3180</ArticleId><ArticleId IdType="pmc">PMC4589158</ArticleId><ArticleId IdType="pubmed">26006013</ArticleId></ArticleIdList></Reference><Reference><Citation>Neil JA, Matsuzawa-Ishimoto Y, Kernbauer-Hölzl E, Schuster SL, Sota S, Venzon M, et al. . IFN-I and IL-22 mediate protective effects of intestinal viral infection. Nat Microbiol (2019) 4:1737–49. doi: 10.1038/s41564-019-0470-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-019-0470-1</ArticleId><ArticleId IdType="pmc">PMC6871771</ArticleId><ArticleId IdType="pubmed">31182797</ArticleId></ArticleIdList></Reference><Reference><Citation>Cieza RJ, Golob JL, Colacino JA, Wobus CE. Comparative analysis of public RNA-sequencing data from human intestinal enteroid (HIEs) infected with enteric RNA viruses identifies universal and virus-specific epithelial responses. Viruses (2021) 13:1059. doi: 10.3390/v13061059</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13061059</ArticleId><ArticleId IdType="pmc">PMC8227290</ArticleId><ArticleId IdType="pubmed">34205050</ArticleId></ArticleIdList></Reference><Reference><Citation>Chhabra P, de Graaf M, Parra GI, Chan MC-W, Green K, Martella V, et al. . Updated classification of norovirus genogroups and genotypes. J Gen Virol (2019) 100:1393–406. doi: 10.1099/jgv.0.001318</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.001318</ArticleId><ArticleId IdType="pmc">PMC7011714</ArticleId><ArticleId IdType="pubmed">31483239</ArticleId></ArticleIdList></Reference><Reference><Citation>Franck KT, Fonager J, Ersbøll AK, Böttiger B. Norovirus epidemiology in community and health care settings and association with patient age, Denmark. Emerg Infect Dis (2014) 20:1123–31. doi: 10.3201/eid2007.130781</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2007.130781</ArticleId><ArticleId IdType="pmc">PMC4073851</ArticleId><ArticleId IdType="pubmed">24960024</ArticleId></ArticleIdList></Reference><Reference><Citation>Vega E, Barclay L, Gregoricus N, Shirley SH, Lee D, Vinjé J. Genotypic and epidemiologic trends of norovirus outbreaks in the united states, 2009 to 2013. J Clin Microbiol (2014) 52:147–55. doi: 10.1128/JCM.02680-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02680-13</ArticleId><ArticleId IdType="pmc">PMC3911414</ArticleId><ArticleId IdType="pubmed">24172151</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones MK, Grau KR, Costantini V, Kolawole AO, de Graaf M, Freiden P, et al. . Human norovirus culture in b cells. Nat Protoc (2015) 10:1939–47. doi: 10.1038/nprot.2015.121</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2015.121</ArticleId><ArticleId IdType="pmc">PMC4689599</ArticleId><ArticleId IdType="pubmed">26513671</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones MK, Watanabe M, Zhu S, Graves CL, Keyes LR, Grau KR, et al. . Enteric bacteria promote human and mouse norovirus infection of b cells. Science (80-) (2014) 346:755–9. doi: 10.1126/science.1257147</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1257147</ArticleId><ArticleId IdType="pmc">PMC4401463</ArticleId><ArticleId IdType="pubmed">25378626</ArticleId></ArticleIdList></Reference><Reference><Citation>Ettayebi K, Crawford SE, Murakami K, Broughman JR, Karandikar U, Tenge VR, et al. . Replication of human noroviruses in stem cell-derived human enteroids. Science (80-) (2016) 353:1387–93. doi: 10.1126/science.aaf5211</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf5211</ArticleId><ArticleId IdType="pmc">PMC5305121</ArticleId><ArticleId IdType="pubmed">27562956</ArticleId></ArticleIdList></Reference><Reference><Citation>Karandikar UC, Crawford SE, Ajami NJ, Murakami K, Kou B, Ettayebi K, et al. . Detection of human norovirus in intestinal biopsies from immunocompromised transplant patients. J Gen Virol (2016) 97:2291–300. doi: 10.1099/jgv.0.000545</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000545</ArticleId><ArticleId IdType="pmc">PMC5756488</ArticleId><ArticleId IdType="pubmed">27412790</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JR, Gilmour K, Breuer J. Norovirus infections occur in b-Cell-Deficient patients. Clin Infect Dis (2016) 62:1136–8. doi: 10.1093/cid/ciw060</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciw060</ArticleId><ArticleId IdType="pubmed">26908782</ArticleId></ArticleIdList></Reference><Reference><Citation>Green KY, Kaufman SS, Nagata BM, Chaimongkol N, Kim DY, Levenson EA, et al. . Human norovirus targets enteroendocrine epithelial cells in the small intestine. Nat Commun (2020) 11:2759. doi: 10.1038/s41467-020-16491-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-16491-3</ArticleId><ArticleId IdType="pmc">PMC7265440</ArticleId><ArticleId IdType="pubmed">32488028</ArticleId></ArticleIdList></Reference><Reference><Citation>Costantini V, Morantz EK, Browne H, Ettayebi K, Zeng X-L, Atmar RL, et al. . Human norovirus replication in human intestinal enteroids as model to evaluate virus inactivation. Emerg Infect Dis (2018) 24:1453–64. doi: 10.3201/eid2408.180126</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2408.180126</ArticleId><ArticleId IdType="pmc">PMC6056096</ArticleId><ArticleId IdType="pubmed">30014841</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarado G, Ettayebi K, Atmar RL, Bombardi RG, Kose N, Estes MK, et al. . Human monoclonal antibodies that neutralize pandemic GII.4 noroviruses. Gastroenterology (2018) 155:1898–907. doi: 10.1053/j.gastro.2018.08.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2018.08.039</ArticleId><ArticleId IdType="pmc">PMC6402321</ArticleId><ArticleId IdType="pubmed">30170116</ArticleId></ArticleIdList></Reference><Reference><Citation>Atmar RL, Ettayebi K, Ayyar BV, Neill FH, Braun RP, Ramani S, et al. . Comparison of microneutralization and histo-blood group antigen-blocking assays for functional norovirus antibody detection. J Infect Dis (2020) 221:739–43. doi: 10.1093/infdis/jiz526</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiz526</ArticleId><ArticleId IdType="pmc">PMC8483564</ArticleId><ArticleId IdType="pubmed">31613328</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosmillo M, Chaudhry Y, Nayak K, Sorgeloos F, Koo B-K, Merenda A, et al. . Norovirus replication in human intestinal epithelial cells is restricted by the interferon-induced JAK/STAT signaling pathway and RNA polymerase II-mediated transcriptional responses. MBio (2020) 11:e00215–20. doi: 10.1128/mBio.00215-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00215-20</ArticleId><ArticleId IdType="pmc">PMC7078467</ArticleId><ArticleId IdType="pubmed">32184238</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahun AS, Goodfellow IG. Interferon responses to norovirus infections: current and future perspectives. J Gen Virol (2021) 102:001660. doi: 10.1099/jgv.0.001660</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.001660</ArticleId><ArticleId IdType="pmc">PMC8604187</ArticleId><ArticleId IdType="pubmed">34698626</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L, Han J, Yan T, Li L, Li J, Ao Y, et al. . Replication and transcriptionomic analysis of human noroviruses in human intestinal enteroids. Am J Transl Res (2019) 11:3365–74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6614657</ArticleId><ArticleId IdType="pubmed">31312350</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin S-C, Qu L, Ettayebi K, Crawford SE, Blutt SE, Robertson MJ, et al. . Human norovirus exhibits strain-specific sensitivity to host interferon pathways in human intestinal enteroids. Proc Natl Acad Sci U S A (2020) 117:23782–93. doi: 10.1073/pnas.2010834117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2010834117</ArticleId><ArticleId IdType="pmc">PMC7519316</ArticleId><ArticleId IdType="pubmed">32907944</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan JCM, Mohammad KN, Zhang L-Y, Wong SH, Chan MC-W. Targeted profiling of immunological genes during norovirus replication in human intestinal enteroids. Viruses (2021) 13:1–21. doi: 10.3390/v13020155</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13020155</ArticleId><ArticleId IdType="pmc">PMC7910953</ArticleId><ArticleId IdType="pubmed">33494515</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirabelli C, Jones MK, Young VL, Kolawole AO, Owusu I, Shan M, et al. . Human norovirus triggers primary B cell immune activation. In Vitro. MBio (2022) 13:e0017522. doi: 10.1128/mbio.00175-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.00175-22</ArticleId><ArticleId IdType="pmc">PMC9040803</ArticleId><ArticleId IdType="pubmed">35404121</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDuff DA, Baldridge MT, Qaqish AM, Nice TJ, Darbandi AD, Hartley VL, et al. . HOIL1 is essential for the induction of type I and III interferons by MDA5 and regulates persistent murine norovirus infection. J Virol (2018) 92:e01368–18. doi: 10.1128/JVI.01368-18</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01368-18</ArticleId><ArticleId IdType="pmc">PMC6232484</ArticleId><ArticleId IdType="pubmed">30209176</ArticleId></ArticleIdList></Reference><Reference><Citation>Nice TJ, Osborne LC, Tomov VT, Artis D, Wherry EJ, Virgin HW. Type I interferon receptor deficiency in dendritic cells facilitates systemic murine norovirus persistence despite enhanced adaptive immunity. PLoS Pathog (2016) 12:e1005684. doi: 10.1371/journal.ppat.1005684</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005684</ArticleId><ArticleId IdType="pmc">PMC4915689</ArticleId><ArticleId IdType="pubmed">27327515</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth AN, Aravamudhan P, Fernández de Castro I, Tenorio R, Risco C, Dermody TS. Ins and outs of reovirus: Vesicular trafficking in viral entry and egress. Trends Microbiol (2021) 29:363–75. doi: 10.1016/j.tim.2020.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2020.09.004</ArticleId><ArticleId IdType="pmc">PMC7523517</ArticleId><ArticleId IdType="pubmed">33008713</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouziat R, Hinterleitner R, Brown JJ, Stencel-Baerenwald JE, Ikizler M, Mayassi T, et al. . Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease. Science (80-) (2017) 356:44–50. doi: 10.1126/science.aah5298</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aah5298</ArticleId><ArticleId IdType="pmc">PMC5506690</ArticleId><ArticleId IdType="pubmed">28386004</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JJ, Jabri B, Dermody TS. A viral trigger for celiac disease. PLoS Pathog (2018) 14:e1007181. doi: 10.1371/journal.ppat.1007181</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007181</ArticleId><ArticleId IdType="pmc">PMC6147651</ArticleId><ArticleId IdType="pubmed">30235320</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Li P, Wang Y, Yin Y, de Ruiter PE, Verstegen MMA, et al. . Rotavirus infection and cytopathogenesis in human biliary organoids potentially recapitulate biliary atresia development. MBio (2020) 11:e1000280. doi: 10.1128/mBio.01968-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01968-20</ArticleId><ArticleId IdType="pmc">PMC7448284</ArticleId><ArticleId IdType="pubmed">32843549</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena K, Blutt SE, Ettayebi K, Zeng X-L, Broughman JR, Crawford SE, et al. . Human intestinal enteroids: a new model to study human rotavirus infection, host restriction, and pathophysiology. J Virol (2016) 90:43–56. doi: 10.1128/JVI.01930-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01930-15</ArticleId><ArticleId IdType="pmc">PMC4702582</ArticleId><ArticleId IdType="pubmed">26446608</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Y, Bijvelds M, Dang W, Xu L, van der Eijk AA, Knipping K, et al. . Modeling rotavirus infection and antiviral therapy using primary intestinal organoids. Antiviral Res (2015) 123:120–31. doi: 10.1016/j.antiviral.2015.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2015.09.010</ArticleId><ArticleId IdType="pubmed">26408355</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu S, Ding S, Wang P, Wei Z, Pan W, Palm NW, et al. . Nlrp9b inflammasome restricts rotavirus infection in intestinal epithelial cells. Nature (2017) 546:667–70. doi: 10.1038/nature22967</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22967</ArticleId><ArticleId IdType="pmc">PMC5787375</ArticleId><ArticleId IdType="pubmed">28636595</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold MM, Barro M, Patton JT. Rotavirus NSP1 mediates degradation of interferon regulatory factors through targeting of the dimerization domain. J Virol (2013) 87:9813–21. doi: 10.1128/jvi.01146-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01146-13</ArticleId><ArticleId IdType="pmc">PMC3754143</ArticleId><ArticleId IdType="pubmed">23824805</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold MM. The rotavirus interferon antagonist NSP1: Many targets, many questions. J Virol (2016) 90:5212–5. doi: 10.1128/jvi.03068-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.03068-15</ArticleId><ArticleId IdType="pmc">PMC4934742</ArticleId><ArticleId IdType="pubmed">27009959</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding S, Mooney N, Li B, Kelly MR, Feng N, Loktev AV, et al. . Comparative proteomics reveals strain-specific β-TrCP degradation via rotavirus NSP1 hijacking a host cullin-3-Rbx1 complex. PLoS Pathog (2016) 12:1–29. doi: 10.1371/journal.ppat.1005929</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005929</ArticleId><ArticleId IdType="pmc">PMC5051689</ArticleId><ArticleId IdType="pubmed">27706223</ArticleId></ArticleIdList></Reference><Reference><Citation>Graff JW, Ettayebi K, Hardy ME. Rotavirus NSP1 inhibits NFκB activation by inducing proteasome-dependent degradation of β-TrCP: A novel mechanism of IFN antagonism. PLoS Pathog (2009) 5:e1000280. doi: 10.1371/journal.ppat.1000280</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000280</ArticleId><ArticleId IdType="pmc">PMC2627925</ArticleId><ArticleId IdType="pubmed">19180189</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagbom M, Istrate C, Engblom D, Karlsson T, Rodriguez-Diaz J, Buesa J, et al. . Rotavirus stimulates release of serotonin (5-HT) from human enterochromaffin cells and activates brain structures involved in nausea and vomiting. PLoS Pathog (2011) 7:e1002115. doi: 10.1371/journal.ppat.1002115</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002115</ArticleId><ArticleId IdType="pmc">PMC3136449</ArticleId><ArticleId IdType="pubmed">21779163</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J-D, Feng N, Sen A, Balan M, Tseng H-C, McElrath C, et al. . Distinct roles of type I and type III interferons in intestinal immunity to homologous and heterologous rotavirus infections. PLoS Pathog (2016) 12:e1005600. doi: 10.1371/journal.ppat.1005600</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005600</ArticleId><ArticleId IdType="pmc">PMC4851417</ArticleId><ArticleId IdType="pubmed">27128797</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Winkle JA, Peterson ST, Kennedy EA, Wheadon MJ, Ingle H, Desai C, et al. . Homeostatic interferon-lambda response to bacterial microbiota stimulates preemptive antiviral defense within discrete pockets of intestinal epithelium. Elife (2022) 11:1–30. doi: 10.7554/eLife.74072</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.74072</ArticleId><ArticleId IdType="pmc">PMC8853662</ArticleId><ArticleId IdType="pubmed">35137688</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding S, Diep J, Feng N, Ren L, Li B, Ooi YS, et al. . STAG2 deficiency induces interferon responses via cGAS-STING pathway and restricts virus infection. Nat Commun (2018) 9:1485. doi: 10.1038/s41467-018-03782-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-03782-z</ArticleId><ArticleId IdType="pmc">PMC5902600</ArticleId><ArticleId IdType="pubmed">29662124</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Kalugotla G, Ingle H, Rodgers R, Wu C, Wang Y, et al. . Intestinal antiviral signaling is controlled by autophagy gene Epg5 independent of the microbiota. Autophagy (2021) 00:1–16. doi: 10.1080/15548627.2021.1968607</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2021.1968607</ArticleId><ArticleId IdType="pmc">PMC9196718</ArticleId><ArticleId IdType="pubmed">34520306</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanifer ML, Mukenhirn M, Muenchau S, Pervolaraki K, Kanaya T, Albrecht D, et al. . Asymmetric distribution of TLR3 leads to a polarized immune response in human intestinal epithelial cells. Nat Microbiol (2020) 5:181–91. doi: 10.1038/s41564-019-0594-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-019-0594-3</ArticleId><ArticleId IdType="pubmed">31686029</ArticleId></ArticleIdList></Reference><Reference><Citation>Pervolaraki K, Stanifer ML, Münchau S, Renn LA, Albrecht D, Kurzhals S, et al. . Type I and type III interferons display different dependency on mitogen-activated protein kinases to mount an antiviral state in the human gut. Front Immunol (2017) 8:459. doi: 10.3389/fimmu.2017.00459</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00459</ArticleId><ArticleId IdType="pmc">PMC5399069</ArticleId><ArticleId IdType="pubmed">28484457</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosch A, Pintó RM, Guix S. Human astroviruses. Clin Microbiol Rev (2014) 27:1048–74. doi: 10.1128/CMR.00013-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00013-14</ArticleId><ArticleId IdType="pmc">PMC4187635</ArticleId><ArticleId IdType="pubmed">25278582</ArticleId></ArticleIdList></Reference><Reference><Citation>Wohlgemuth N, Honce R, Schultz-Cherry S. Astrovirus evolution and emergence. Infect Genet Evol (2019) 69:30–7. doi: 10.1016/j.meegid.2019.01.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2019.01.009</ArticleId><ArticleId IdType="pmc">PMC7106029</ArticleId><ArticleId IdType="pubmed">30639546</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortez V, Meliopoulos VA, Karlsson EA, Hargest V, Johnson C, Schultz-Cherry S. Astrovirus biology and pathogenesis. Annu Rev Virol (2017) 4:327–48. doi: 10.1146/annurev-virology-101416-041742</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-101416-041742</ArticleId><ArticleId IdType="pubmed">28715976</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkbeiner SR, Holtz LR, Jiang Y, Rajendran P, Franz CJ, Zhao G, et al. . Human stool contains a previously unrecognized diversity of novel astroviruses. Virol J (2009) 6:161. doi: 10.1186/1743-422X-6-161</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-6-161</ArticleId><ArticleId IdType="pmc">PMC2765957</ArticleId><ArticleId IdType="pubmed">19814825</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokoyama CC, Loh J, Zhao G, Stappenbeck TS, Wang D, Huang HV, et al. . Adaptive immunity restricts replication of novel murine astroviruses. J Virol (2012) 86:12262–70. doi: 10.1128/JVI.02018-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02018-12</ArticleId><ArticleId IdType="pmc">PMC3486451</ArticleId><ArticleId IdType="pubmed">22951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinker JP, Blacklow NR, Herrmann JE. Human astrovirus isolation and propagation in multiple cell lines. Arch Virol (2000) 145:1847–56. doi: 10.1007/s007050070060</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s007050070060</ArticleId><ArticleId IdType="pubmed">11043945</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolawole AO, Mirabelli C, Hill DR, Svoboda SA, Janowski AB, Passalacqua KD, et al. . Astrovirus replication in human intestinal enteroids reveals multi-cellular tropism and an intricate host innate immune landscape. PLoS Pathog (2019) 15:e1008057. doi: 10.1371/journal.ppat.1008057</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008057</ArticleId><ArticleId IdType="pmc">PMC6957189</ArticleId><ArticleId IdType="pubmed">31671153</ArticleId></ArticleIdList></Reference><Reference><Citation>Lion T. Adenovirus persistence, reactivation, and clinical management. FEBS Lett (2019) 593:3571–82. doi: 10.1002/1873-3468.13576</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.13576</ArticleId><ArticleId IdType="pubmed">31411731</ArticleId></ArticleIdList></Reference><Reference><Citation>Lion T. Adenovirus infections in immunocompetent and immunocompromised patients. Clin Microbiol Rev (2014) 27:441–62. doi: 10.1128/CMR.00116-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00116-13</ArticleId><ArticleId IdType="pmc">PMC4135893</ArticleId><ArticleId IdType="pubmed">24982316</ArticleId></ArticleIdList></Reference><Reference><Citation>Lion T, Kosulin K, Landlinger C, Rauch M, Preuner S, Jugovic D, et al. . Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation. Leukemia (2010) 24:706–14. doi: 10.1038/leu.2010.4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/leu.2010.4</ArticleId><ArticleId IdType="pubmed">20147979</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee B, Damon CF, Platts-Mills JA. Pediatric acute gastroenteritis associated with adenovirus 40/41 in low-income and middle-income countries. Curr Opin Infect Dis (2020) 33:398–403. doi: 10.1097/QCO.0000000000000663</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000663</ArticleId><ArticleId IdType="pmc">PMC8286627</ArticleId><ArticleId IdType="pubmed">32773498</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M, Lim MY, Ko G. Enhancement of enteric adenovirus cultivation by viral transactivator proteins. Appl Environ Microbiol (2010) 76:2509–16. doi: 10.1128/AEM.02224-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.02224-09</ArticleId><ArticleId IdType="pmc">PMC2849201</ArticleId><ArticleId IdType="pubmed">20139315</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P, Yang L, Guo J, Zou W, Xu X, Yang X, et al. . Circulation of HAdV-41 with diverse genome types and recombination in acute gastroenteritis among children in Shanghai/631/326/421/631/326/325/2483/45/23 article. Sci Rep (2017) 7:1–9. doi: 10.1038/s41598-017-01293-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-01293-3</ArticleId><ArticleId IdType="pmc">PMC5471248</ArticleId><ArticleId IdType="pubmed">28615624</ArticleId></ArticleIdList></Reference><Reference><Citation>Holly MK, Smith JG. Adenovirus infection of human enteroids reveals interferon sensitivity and preferential infection of goblet cells. J Virol (2018) 92:e00250–18. doi: 10.1128/JVI.00250-18</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00250-18</ArticleId><ArticleId IdType="pmc">PMC5899204</ArticleId><ArticleId IdType="pubmed">29467318</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosulin K, Geiger E, Vécsei A, Huber WD, Rauch M, Brenner E, et al. . Persistence and reactivation of human adenoviruses in the gastrointestinal tract. Clin Microbiol Infect (2016) 22:381.e1–8. doi: 10.1016/j.cmi.2015.12.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2015.12.013</ArticleId><ArticleId IdType="pubmed">26711435</ArticleId></ArticleIdList></Reference><Reference><Citation>Diez-Valcarce M, Castro CJ, Marine RL, Halasa N, Mayta H, Saito M, et al. . Genetic diversity of human sapovirus across the americas. J Clin Virol (2018) 104:65–72. doi: 10.1016/j.jcv.2018.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2018.05.003</ArticleId><ArticleId IdType="pmc">PMC8972816</ArticleId><ArticleId IdType="pubmed">29753103</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker-Dreps S, Bucardo F, Vinjé J. Sapovirus: an important cause of acute gastroenteritis in children. Lancet Child Adolesc Heal (2019) 3:758–9. doi: 10.1016/S2352-4642(19)30270-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(19)30270-6</ArticleId><ArticleId IdType="pmc">PMC7213765</ArticleId><ArticleId IdType="pubmed">31439497</ArticleId></ArticleIdList></Reference><Reference><Citation>Platts-Mills JA, Liu J, Rogawski ET, Kabir F, Lertsethtakarn P, Siguas M, et al. . Use of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings: a reanalysis of the MAL-ED cohort study. Lancet Glob Heal (2018) 6:e1309–18. doi: 10.1016/S2214-109X(18)30349-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(18)30349-8</ArticleId><ArticleId IdType="pmc">PMC6227251</ArticleId><ArticleId IdType="pubmed">30287127</ArticleId></ArticleIdList></Reference><Reference><Citation>Oka T, Stoltzfus GT, Zhu C, Jung K, Wang Q, Saif LJ. Attempts to grow human noroviruses, a sapovirus, and a bovine norovirus in vitro . PLoS One (2018) 13:e0178157. doi: 10.1371/journal.pone.0178157</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0178157</ArticleId><ArticleId IdType="pmc">PMC5810978</ArticleId><ArticleId IdType="pubmed">29438433</ArticleId></ArticleIdList></Reference><Reference><Citation>Takagi H, Oka T, Shimoike T, Saito H, Kobayashi T, Takahashi T, et al. . Human sapovirus propagation in human cell lines supplemented with bile acids. Proc Natl Acad Sci U S A (2020) 117:32078–85. doi: 10.1073/pnas.2007310117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2007310117</ArticleId><ArticleId IdType="pmc">PMC7749338</ArticleId><ArticleId IdType="pubmed">33257564</ArticleId></ArticleIdList></Reference><Reference><Citation>Drummond CG, Bolock AM, Ma C, Luke CJ, Good M, Coyne CB. Enteroviruses infect human enteroids and induce antiviral signaling in a cell lineage-specific manner. Proc Natl Acad Sci U S A (2017) 114:1672–7. doi: 10.1073/pnas.1617363114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1617363114</ArticleId><ArticleId IdType="pmc">PMC5320971</ArticleId><ArticleId IdType="pubmed">28137842</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang JO-L, Zhou J, Zhao X, Li C, Zou Z, Yin F, et al. . Development of three-dimensional human intestinal organoids as a physiologically relevant model for characterizing the viral replication kinetics and antiviral susceptibility of enteroviruses. Biomedicines (2021) 9:88. doi: 10.3390/biomedicines9010088</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9010088</ArticleId><ArticleId IdType="pmc">PMC7831294</ArticleId><ArticleId IdType="pubmed">33477611</ArticleId></ArticleIdList></Reference><Reference><Citation>Good C, Wells AI, Coyne CB. Type III interferon signaling restricts enterovirus 71 infection of goblet cells. Sci Adv (2019) 5:1–12. doi: 10.1126/sciadv.aau4255</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aau4255</ArticleId><ArticleId IdType="pmc">PMC6402847</ArticleId><ArticleId IdType="pubmed">30854425</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nat Rev Microbiol (2022) 20:270–84. doi: 10.1038/s41579-022-00713-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00713-0</ArticleId><ArticleId IdType="pubmed">35354968</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong SH, Lui RNS, Sung JJY. Covid-19 and the digestive system. J Gastroenterol Hepatol (2020) 35:744–8. doi: 10.1111/jgh.15047</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgh.15047</ArticleId><ArticleId IdType="pubmed">32215956</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Guo C, Tang L, Hong Z, Zhou J, Dong X, et al. . Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol (2020) 5:434–5. doi: 10.1016/S2468-1253(20)30083-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(20)30083-2</ArticleId><ArticleId IdType="pmc">PMC7158584</ArticleId><ArticleId IdType="pubmed">32199469</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers MM, Beumer J, van der Vaart J, Knoops K, Puschhof J, Breugem TI, et al. . SARS-CoV-2 productively infects human gut enterocytes. Science (80-) (2020) 369:50–4. doi: 10.1126/science.abc1669</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc1669</ArticleId><ArticleId IdType="pmc">PMC7199907</ArticleId><ArticleId IdType="pubmed">32358202</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanifer ML, Kee C, Cortese M, Zumaran CM, Triana S, Mukenhirn M, et al. . Critical role of type III interferon in controlling SARS-CoV-2 infection in human intestinal epithelial cells. Cell Rep (2020) 32:107863. doi: 10.1016/j.celrep.2020.107863</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.107863</ArticleId><ArticleId IdType="pmc">PMC7303637</ArticleId><ArticleId IdType="pubmed">32610043</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Li C, Liu X, Chiu MC, Zhao X, Wang D, et al. . Infection of bat and human intestinal organoids by SARS-CoV-2. Nat Med (2020) 26:1077–83. doi: 10.1038/s41591-020-0912-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0912-6</ArticleId><ArticleId IdType="pubmed">32405028</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang R, Gomez Castro MF, McCune BT, Zeng Q, Rothlauf PW, Sonnek NM, et al. . TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Sci Immunol (2020) 5:eabc3582. doi: 10.1126/sciimmunol.abc3582</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abc3582</ArticleId><ArticleId IdType="pmc">PMC7285829</ArticleId><ArticleId IdType="pubmed">32404436</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, Duan X, Yang L, Nilsson-Payant BE, Wang P, Duan F, et al. . Identification of SARS-CoV-2 inhibitors using lung and colonic organoids. Nature (2021) 589:270–5. doi: 10.1038/s41586-020-2901-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2901-9</ArticleId><ArticleId IdType="pmc">PMC8034380</ArticleId><ArticleId IdType="pubmed">33116299</ArticleId></ArticleIdList></Reference><Reference><Citation>Triana S, Metz-Zumaran C, Ramirez C, Kee C, Doldan P, Shahraz M, et al. . Single-cell analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut. Mol Syst Biol (2021) 17:1–25. doi: 10.15252/msb.202110232</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.202110232</ArticleId><ArticleId IdType="pmc">PMC8077299</ArticleId><ArticleId IdType="pubmed">33904651</ArticleId></ArticleIdList></Reference><Reference><Citation>Metz-Zumaran C, Kee C, Doldan P, Guo C, Stanifer ML, Boulant S. Increased sensitivity of SARS-CoV-2 to type III interferon in human intestinal epithelial cells. J Virol (2022) 96:e0170521. doi: 10.1128/jvi.01705-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01705-21</ArticleId><ArticleId IdType="pmc">PMC9006957</ArticleId><ArticleId IdType="pubmed">35262371</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>